DexCom Net Income From Continuing Ops from 2010 to 2026

DC4 Stock  EUR 61.93  0.59  0.96%   
DexCom's Net Income From Continuing Ops is increasing over the last several years with slightly volatile swings. Net Income From Continuing Ops is estimated to finish at about 878.1 M this year. During the period from 2010 to 2026 DexCom Inc Net Income From Continuing Ops regressed destribution of quarterly values had mean deviationof  285,648,893 and mean square error of 33254.1 T. View All Fundamentals
 
Net Income From Continuing Ops  
First Reported
2016-12-31
Previous Quarter
283.8 M
Current Value
267.3 M
Quarterly Volatility
102.5 M
 
Covid
 
Interest Hikes
Check DexCom financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DexCom's main balance sheet or income statement drivers, such as Interest Expense of 31.7 M, Selling General Administrative of 742.9 M or Total Revenue of 4.9 B, as well as many indicators such as . DexCom financial statements analysis is a perfect complement when working with DexCom Valuation or Volatility modules.
  
This module can also supplement various DexCom Technical models . Check out the analysis of DexCom Correlation against competitors.
The Net Income From Continuing Ops trend for DexCom Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether DexCom is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest DexCom's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of DexCom Inc over the last few years. It is DexCom's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DexCom's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

DexCom Net Income From Continuing Ops Regression Statistics

Arithmetic Mean206,483,235
Coefficient Of Variation162.17
Mean Deviation285,648,893
Median(22,400,000)
Standard Deviation334,843,980
Sample Variance112120.5T
Range1B
R-Value0.85
Mean Square Error33254.1T
R-Squared0.72
Significance0.000016
Slope56,340,980
Total Sum of Squares1793927.9T

DexCom Net Income From Continuing Ops History

2026878.1 M
2025836.3 M
2024576.2 M
2023541.5 M
2022341.2 M
2021154.7 M
2020493.6 M

About DexCom Financial Statements

DexCom stakeholders use historical fundamental indicators, such as DexCom's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although DexCom investors may analyze each financial statement separately, they are all interrelated. For example, changes in DexCom's assets and liabilities are reflected in the revenues and expenses on DexCom's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in DexCom Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Income From Continuing Ops836.3 M878.1 M

Currently Active Assets on Macroaxis

When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:
Check out the analysis of DexCom Correlation against competitors.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
It's important to distinguish between DexCom's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DexCom should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, DexCom's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.